The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 28, 2020
Filed:
Aug. 31, 2018
Applicant:
Lutris Pharma Ltd., Tel Aviv, IL;
Inventor:
Noa Shelach, Tel Aviv, IL;
Assignee:
Lutris Pharma Ltd., Tel Aviv, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/52 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/404 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/4375 (2006.01); A61K 31/519 (2006.01); A61P 17/00 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01);
U.S. Cl.
CPC ...
A61K 31/52 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 31/167 (2013.01); A61K 31/404 (2013.01); A61K 31/4375 (2013.01); A61K 31/44 (2013.01); A61K 31/4439 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61P 17/00 (2018.01);
Abstract
The invention discloses compositions comprising BRaf inhibitors and uses thereof for treating and/or preventing by topical or systemic administration cutaneous conditions caused by treatment with EGFR inhibitors and/or PI3K inhibitors.